Bajaj Healthcare Limited

Web: bajajhealth.com NSE: BAJAJHCARE BSE: 539872 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

324 1(0%)

Volume

2L as on 23, Jun

Open

569

High

589

Low

550

Close

325

VWAP

316

52 Week High

516

52 Week Low

272

Viand Research Rating
Quality Score

60/100

Growth Score

66/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

1,091

No. of Shares

3.37

P/E

-80.33

P/B

4.48

Face Value

5

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

-5.58

ROCE

-

Profit Growth

-

Listing Date

25-Nov-21

Promoter Holding

58.59%

FII Holding

2.19%

DII Holding

1.92%

Price Chart
Price Performance
1 Week4%
1 Month3%
3 Months3%
6 Months0%
1 Year0%
YTD0%
Moving Average
5 Day SMA312
10 Day SMA304
20 Day SMA301
30 Day SMA299
50 Day SMA312
61 Day SMA312
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3328320325327
Resistance 2325319322325
Resistance 1321318321321
Pivot Point318318318318
Support 1315317316315
Support 2312317315312
Support 3309316312308
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,56,65518990%2%9%21%3757.70.0711509
2DIVISLAB2,43,19691612%8%44%51%6957.702568
3TORNTPHARM1,84,30348462%3%12%36%7257.71.792138
4APOLLOHOSP1,24,83486501%1%12%10%5857.70.92003
5ZYDUSLIFE1,12,89711324%2%26%13%2057.70.465124
6CIPLA1,11,34613852%5%3%12%2257.70.023862
7LAURUSLABS99,63418443%3%75%114%057.70.48890
8DRREDDY96,96211512%2%11%8%2057.70.24158
9MAXHEALTH96,6469851%10%8%14%057.70.321442
10LUPIN96,62021131%11%8%10%2357.70.295355
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.31) 58.59%(-0.91) 58.29%(0.01) 59.19%(0.01) 59.19%(0.01) 59.19%(0.01) 59.19%(0.01) 59.19%(-8.61) 59.19%(0.01) 67.74%(0.01) 67.74%(0.01) 67.73%(0.21) 67.69%(0.01) 67.49%(0.11) 67.49%(0.11) 67.42%(0.01) 67.30%(0.01) 67.30%(0.01) 67.26%(0.01) 67.26%(0.01) 67.26%
FIIs(0.21) 2.19%(0.81) 1.98%(0.11) 1.18%(0.01) 1.12%(0.01) 1.09%(0.01) 1.05%(-0.11) 1.01%(1.11) 1.07%(-0.51) 0.00%(-0.21) 0.53%(0.11) 0.74%(0.01) 0.66%(-0.11) 0.69%(-0.21) 0.78%(0.91) 0.94%(-0.21) 0.09%(-0.11) 0.32%(0.11) 0.38%(0.01) 0.32%(0.01) 0.34%
DIIs(-1.01) 1.92%(0.01) 2.91%(0.01) 2.96%(-0.21) 2.99%(0.61) 3.16%(0.21) 2.52%(0.41) 2.36%(2.01) 1.97%(-0.41) 0.00%(-0.11) 0.43%(0.11) 0.48%(0.11) 0.43%(0.01) 0.34%(0.01) 0.34%(0.31) 0.34%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
Public37.30%36.82%36.67%36.70%36.56%37.25%37.45%37.77%32.27%31.31%31.06%31.22%31.48%31.38%31.30%32.62%32.38%32.36%32.42%32.39%
No. of Shareholders41,31038,15837,95338,57635,98035,71032,67231,99532,39732,71229,62628,00827,32226,03726,93029,76930,90930,72332,30926,707
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
Sales166153161148149154123133132134109101130154133195172176167.57
Sales Growth % (YoY)11.3%-0.9%31.3%11.1%12.5%15.4%13.1%31.5%1.9%-13.1%-18.1%-48.2%-24.6%----32.9%-6%
Sales Growth % (QoQ)8.5%-5%8.8%-0.7%-3.2%25.2%-7.5%0.8%-1.5%22.9%7.9%-22.3%-15.6%15.8%-31.8%13.4%-2.3%5%-
Expenses1371301311211241431011091081188982108132102161146150136.75
Operating Profit29233127251222252416201922223034262530.82
OPM %1715191816818181912181917142318151418.39
Other Income1-3410113-140-36-7-7-55-7-6-5100.2
Interest6666566886789654442.84
Depreciation7877687777776544744.86
Profit before tax16-24191514118149-33-1-3-4851522161723.32
Tax %16-61724171-393023-10584021262626-325.21
Net Profit 14-23161112111297-30-2-3-4841116121717.45
Net Profit Growth % (QoQ)160.9%-243.8%45.5%-8.3%9.1%-8.3%33.3%28.6%123.3%-1400%33.3%93.8%-1300%-63.6%-31.2%33.3%-29.4%-2.6%-
Net Profit Growth % (YoY)16.7%-309.1%33.3%22.2%71.4%136.7%700%400%114.6%-850%-118.2%-118.8%-500%-76.5%-37%----
TTM Net Profit181650464439-2-16-28-83-49-36-17435662.4546.4534.450
EPS in Rs4.07-6.794.963.523.753.543.7132.58-10.84-0.8-1.25-17.471.345.934.366.336.32
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Sales611543473646680657410370327231223218205171
Sales Growth %12.6%14.6%-26.7%-5%3.5%60.2%10.8%13.2%41.8%3.5%2.1%6.5%20%20.7%
Expenses506460397534561521362327288200193189186158
Operating Profit10583761121191364843393130291913
OPM %17151617172112121213141397
Other Income-3216-105-191771220000
Interest2228301813878888876
Depreciation282828171816121111119998
Profit before tax2343-8658901193624231414123-2
Tax %337-325203030333343393740-31
Net Profit 1640-844371832516158882-1
Net Profit Growth %-60%147.6%-295.3%-39.4%-14.5%232%56.2%6.7%87.5%--300%300%-
EPS in Rs4.6812.51-30.3615.5925.8730.119.145.915.52.833.048.342.19-1.18
Dividend Payout %328-366500500000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Cash from Operating Activity582292-221442125172225281714
Cash from Investing Activity-48-15-11-93-75-109-28-13-12-8-31-17-9-8
Cash from Financing Activity24-6-9713162753-132-135-11-8-7
Net Cash Flow350-1616-1210-40700010
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Equity Capital1716161614141414147777222
Reserves5164714504302653543152451641221079282782826
Borrowings2492382232063334152571819181877581707272
Other Liabilities141114144152154115136867457684539384331
Total Liabilities923839833804765898721526343267268219209189145131
Fixed Assets2482512382402533662702081621281271281301085654
CWIP86310722525751201135
Investments0000000050000000
Other Assets6675825915545065103992601701371409178798772
Total Assets923839833804765898721526343267268219209189145131
Delivery

Delivery Data: BAJAJHCARE

#Date
313
26%
394
Value (Cr)Q/T
54
Del
32
Del
13
14-Sep321
15
83467
23-Sep325
5
41493
32-Sep329
1
25451
41-Sep329
3
26521
531-Aug334
11
33374
628-Aug322
1
24461
727-Aug321
3
32441
826-Aug326
1
26501
925-Aug320
1
32501
1024-Aug322
2
32501
1121-Aug322
2
23481
1220-Aug326
2
32591
1319-Aug319
2
21561
1418-Aug322
2
28461
1517-Aug323
2
28581
1614-Aug329
2
28581
1713-Aug331
5
38332
1812-Aug327
3
23521
1911-Aug329
2
31481
2010-Aug330
3
31411
217-Aug330
3
28481
226-Aug329
3
43522
235-Aug333
2
38481
244-Aug336
3
33481
253-Aug340
4
36522
2631-Jul336
12
31314
2730-Jul327
6
35523
2829-Jul326
6
32513
2928-Jul322
12
46486
3027-Jul320
8
47333
3124-Jul323
10
34323
3223-Jul318
26
39267
3322-Jul323
55
443620
3421-Jul369
34
433111
3520-Jul387
39
464016
3617-Jul374
11
40374
3716-Jul373
26
364010
3815-Jul364
15
41538
3914-Jul348
7
30433
4013-Jul343
6
44473
4110-Jul349
5
39512
429-Jul350
19
32408
438-Jul335
7
29393
447-Jul332
4
32512
456-Jul336
4
29442
463-Jul345
5
32332
472-Jul342
12
48273
481-Jul345
12
46273
4930-Jun351
68
701913
5029-Jun353
525
87525
Daily Market Cap
DateTotal Market CapChangeChg %
04-Sep1,091c30c2.69
03-Sep1,121c3c0.27
01-Sep1,118c3c0.27
31-Aug1,121c35c3.19
27-Aug1,086c6c0.52
26-Aug1,092c15c1.34
25-Aug1,078c6c0.59
24-Aug1,084c12c1.09
21-Aug1,096c25c2.37
19-Aug1,071c17c1.55
18-Aug1,087c17L0.02
17-Aug1,088c21c1.91
14-Aug1,109c22c1.98
13-Aug1,131c31c2.78
12-Aug1,100c12c1.07
11-Aug1,112c67L0.06
10-Aug1,113c67L0.06
06-Aug1,112c16c1.42
04-Aug1,128c3c0.27
31-Jul1,131c28c2.58
30-Jul1,103c3c0.31
29-Jul1,100c22c2.08
28-Jul1,077c34L0.03
27-Jul1,077c10c0.96
24-Jul1,087c00
Stock Checklist
Price is above from 52 week high low average: 21%
Stock is trading above all short term SMAs: YES
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: YES
Mutual Fund Holdings

Held by 4 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹38 Cr · 0 increasing / 2 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
HDFC Mutual Fund20.65%-0.12%38.3
Bandhan Mutual Fund20.05%-0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0